US Bancorp’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-24
| Closed | -$480 | – | 4177 |
|
|
2025
Q1 | $480 | Sell |
24
-1,178
| -98% | -$23.6K | ﹤0.01% | 4028 |
|
|
2024
Q4 | $32K | Sell |
1,202
-3,413
| -74% | -$91K | ﹤0.01% | 2948 |
|
|
2024
Q3 | $132K | Buy |
4,615
+4,383
| +1,889% | +$125K | ﹤0.01% | 2251 |
|
|
2024
Q2 | $5.05K | Sell |
232
-234
| -50% | -$5.1K | ﹤0.01% | 3496 |
|
|
2024
Q1 | $10.3K | Buy |
466
+165
| +55% | +$3.66K | ﹤0.01% | 3318 |
|
|
2023
Q4 | $6.5K | Buy |
301
+23
| +8% | +$496 | ﹤0.01% | 3447 |
|
|
2023
Q3 | $4.7K | Sell |
278
-1
| -0.4% | -$17 | ﹤0.01% | 3436 |
|
|
2023
Q2 | $3.83K | Buy |
279
+40
| +17% | +$549 | ﹤0.01% | 3520 |
|
|
2023
Q1 | $5.43K | Buy |
239
+19
| +9% | +$432 | ﹤0.01% | 3481 |
|
|
2022
Q4 | $5.18K | Sell |
220
-3,363
| -94% | -$79.2K | ﹤0.01% | 3488 |
|
|
2022
Q3 | $93K | Sell |
3,583
-9,224
| -72% | -$239K | ﹤0.01% | 2222 |
|
|
2022
Q2 | $281K | Sell |
12,807
-3,661
| -22% | -$80.3K | ﹤0.01% | 1727 |
|
|
2022
Q1 | $739K | Buy |
16,468
+3,694
| +29% | +$166K | ﹤0.01% | 1325 |
|
|
2021
Q4 | $547K | Sell |
12,774
-816
| -6% | -$34.9K | ﹤0.01% | 1480 |
|
|
2021
Q3 | $904K | Buy |
13,590
+10,151
| +295% | +$675K | ﹤0.01% | 1234 |
|
|
2021
Q2 | $252K | Buy |
3,439
+2,829
| +464% | +$207K | ﹤0.01% | 1871 |
|
|
2021
Q1 | $42K | Buy |
+610
| New | +$42K | ﹤0.01% | 2654 |
|